PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of capmcAbout manuscripts / A propos des manuscritsSubmit manuscript / soumettre un manuscrit
 
From:
Thromb Haemost. Author manuscript; available in PMC Oct 26, 2012.
Published in final edited form as:
Thromb Haemost. Jul 2003; 90(1): 108–115.
doi: 10.1267/THRO03010108
Table 2
Number and percentage of individuals testing positive for aPL.
aPL measuredaPL request
N=208
CBC request
N= 207*
Total
N=415
aCL (IgG or IgM)43 (20.7)§6 (2.9)49(11.8)
aCL IgG32(15.4)2(1.0)34 (8.2)
aCL IgM21(10.1)5 (2.4)26 (6.3)
LAC33 (15.9)7 (3.4)40 (9.6)
aβ2GPI (IgG or IgM)12(5.8)5 (2.4)17(4.1)
aβ2GPI (IgG)9 (4.3)2 (0.9)11 (2.7)
aβ2GPI (IgM)3(1.4)4(1.9)7(1.7)
*aβ2GPI status was not available for one person in the CBC-request group.
aPL positivity were defined as follows: aCL (IgG or IgM) > 15, LAC ≥ 0.6 seconds, and aβ2GPI (IgG or IgM) ≥0.7.
§Number (%) of individuals positive in the group